SavedAdd your journal

Journals / Türk Dermatoloji Dergisi / 2017 / Cilt: 11 - Sayı: 2

Current Approach to Phototherapy Applications in Dermatology Practice: Part 2. Phototherapy in Vitiligo, Mycosis Fungoides, Atopic Dermatitis, Sclerosing Diseases and Psoriasis

Dermatoloji Pratiğinde Fototerapi Uygulamalarına Güncel Yaklaşım: Bölüm 2. Vitiligo, Mikozis Fungoides, Atopik Dermatit, Sklerozan Hastalıklar ve Psoriasiste Fototerapi

Dilek Seçkin GENÇOSMANOĞLU
Pages
51–65
Publication Date
2022-11-03
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, efficacy of different phototherapy methods in the most common diseases treated with phototherapy such as vitiligo, mycosis fungoides, atopic dermatitis, sclerosing diseases and psoriasis will be discussed in light of current guidelines.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Many skin diseases can be treated with phototherapy, however, the method choice depends on the disease's characteristics.
📊
Key Findings & Data:First-line phototherapy for generalized plaque psoriasis is narrowband ultraviolet B whereas it is psoralen and ultraviolet A for plaque stage mycosis fungoides and ultraviolet A1 for severe localized scleroderma.
💡
Conclusion & Impact:In this review, efficacy of different phototherapy methods in the most common diseases treated with phototherapy such as vitiligo, mycosis fungoides, atopic dermatitis, sclerosing diseases and psoriasis will be discussed in light of current guidelines.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Many skin diseases can be treated with phototherapy, however, the method choice depends on the disease's characteristics. First-line phototherapy for generalized plaque psoriasis is narrowband ultraviolet B whereas it is psoralen and ultraviolet A for plaque stage mycosis fungoides and ultraviolet A1 for severe localized scleroderma. In this review, efficacy of different phototherapy methods in the most common diseases treated with phototherapy such as vitiligo, mycosis fungoides, atopic dermatitis, sclerosing diseases and psoriasis will be discussed in light of current guidelines.

Özet

Fototerapiyle çok sayıda dermatolojik hastalık tedavi edilebilir, ancak, hangi hastalıkta hangi yöntemin kullanılacağı, hastalığa ait özelliklerle belirlenmektedir. Örneğin, jeneralize plak psoriasiste birinci basamak fototerapi yöntemi dar bant ultraviyole B iken, plak evre mikozis fungoideste psoralen ve ultraviyole A, yaygın ve şiddetli lokalize sklerodermada ise ultraviyole A1'dir. Bu derlemede, fototerapinin en çok kullanıldığı hastalıklar olan vitiligo, mikozis fungoides, atopik dermatit, sklerozan hastalıklar ve psoriasiste, farklı yöntemlerin etkinliği ile ilgili veriler güncel rehberler ışığında tartışılacaktır.

🔖

Cite This Article

GENÇOSMANOĞLU, D. S. (2022). Current Approach to Phototherapy Applications in Dermatology Practice: Part 2. Phototherapy in Vitiligo, Mycosis Fungoides, Atopic Dermatitis, Sclerosing Diseases and Psoriasis. Türk Dermatoloji Dergisi, Cilt: 11 - Sayı: 2, 51–65. https://ajindex.com/articles/621593

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Alikhan A, Felsten LM, Daly M, et al. Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol 2011;65:473-91
  2. Yones SS, Palmer RA, Garibaldinos TM, et al. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs NarrowbandUV-B therapy. Arch Dermatol 2007;143:578-84
  3. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 1997;133:1525-8
  4. Seçkin D, Fototerapi Çalışma Grubu, Yılmaz E. Türkiye'de foto(kemo)terapi uygulamaları anket sonuçları. Türkderm 2010;44(Özel Sayı 2):131-7
  5. Madigan LM, Al-Jamal M, Hamzavi I. Exploring the gaps in the evidencebased application of narrowband UVB for the treatment of vitiligo. Photodermatol Photoimmunol Photomed 2016;32:66-80
  6. Hofer A, Hassan AS, Legat FJ, et al. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients. Br J Dermatol 2005;152:981-5
  7. Pacifico A, Leone G. Photo (chemo) therapy for vitiligo. Photodermatol Photoimmunol Photomed 2011;27:261-77
  8. Hexsel CL, Mahmoud BH, Mitchell D, et al. A clinical trial and molecular study of photoadaptation in vitiligo. Br J Dermatol 2009;160:534-9
  9. Teulings HE, Overkamp M, Ceylan E, et al. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners. Br J Dermatol 2013;168:162-71
  10. Paradisi A, Tabolli S, Didona B, et al. Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo. J Am Acad Dermatol 2014;71:1110-6
  11. Gawkrodger DJ, Ormerod AD, Shaw L, et al; Therapy Guidelines and Audit Subcommittee, British Association of Dermatologists; Clinical Standards Department, Royal College of Physicians of London; Cochrane Skin Group; Vitiligo Society. Guideline for the diagnosis and management of vitiligo. Br J Dermatol 2008;159:1051-76
  12. Nicolaidou E, Antoniou C, Stratigos AJ, et al. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy. J Am Acad Dermatol 2007;56:274-8
  13. Natta R, Somsak T, Wisuttida T, et al. Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians. J Am Acad Dermatol 2003;49:473- 6
  14. Kishan Kumar YH, Rao GR, Gopal KV, et al. Evaluation of